BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23769975)

  • 1. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
    Pienaar IS; van de Berg W
    Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
    Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
    Elson JL; Yates A; Pienaar IS
    Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
    Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
    Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
    Elson JL; Kochaj R; Reynolds R; Pienaar IS
    Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
    Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
    Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
    Park E; Song I; Jang DP; Kim IY
    Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats].
    Liu H; Lin YH; Cheng JH; Cai Y; Yu JW; Ma J; Gao DM
    Sheng Li Xue Bao; 2011 Aug; 63(4):311-8. PubMed ID: 21861049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
    Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
    Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal activity of thalamic parafascicular nucleus is conversely regulated by nigrostriatal pathway and pedunculopontine nucleus in the rat.
    Yan W; Zhang QJ; Liu J; Wang T; Wang S; Liu X; Chen L; Gui ZH
    Brain Res; 2008 Nov; 1240():204-12. PubMed ID: 18823953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
    Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
    J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The firing activity of presumed cholinergic and non-cholinergic neurons of the pedunculopontine nucleus in 6-hydroxydopamine-lesioned rats: an in vivo electrophysiological study.
    Zhang QJ; Liu J; Wang Y; Wang S; Wu ZH; Yan W; Hui YP; Ali U
    Brain Res; 2008 Dec; 1243():152-60. PubMed ID: 18824158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.
    Witzig VS; Alosaimi F; Temel Y; Schulz JB; Jahanshahi A; Tan SKH
    Neurosci Lett; 2023 Apr; 802():137134. PubMed ID: 36801348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
    Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J
    Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
    Wen P; Li M; Xiao H; Ding R; Chen H; Chang J; Zhou M; Yang Y; Wang J; Zheng W; Zhang W
    Neurosci Lett; 2015 Jul; 600():62-8. PubMed ID: 26054938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
    He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
    Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.